Related Experiment Videos
Injection therapy for subacute and chronic benign low back pain
P J Nelemans1, R A de Bie, H C de Vet
1Epidemiology, University of Maastricht, Debyeplein 1, Maastricht, Netherlands, 6200 MD. Patty.Nelemans@epid.unimaas.nl
The Cochrane Database of Systematic Reviews
|May 5, 2000
Summary
Injection therapies for chronic low back pain lack convincing evidence of effectiveness. More high-quality trials are needed to determine the short- and long-term benefits of facet joint, epidural, and local injections.
Area of Science:
- Pain Management
- Interventional Pain Therapy
- Evidence-Based Medicine
Background:
- Injection therapy, including anesthetics and steroids, is a common treatment for chronic low back pain.
- The effectiveness of these injections for short- and long-term pain relief requires thorough evaluation.
Purpose of the Study:
- To assess the efficacy of injection therapy for low back pain lasting over one month.
- To differentiate effectiveness based on injection site: facet joint, epidural, or local.
Main Methods:
- Systematic review of randomized controlled trials (RCTs) published up to 1996.
- Included studies focused on benign low back pain, excluding cancer-related pain.
- Assessed methodological quality and performed subgroup analyses by control type, injection site, and outcome timing.
Main Results:
- Twenty-one RCTs were included; many had low methodological quality.
- Limited well-designed trials existed, with some showing non-significant short-term and long-term effects for facet joint, epidural, and local injections.
- Pooled relative risks (RR) for explanatory studies indicated no significant benefit, e.g., local injections long-term RR=0.79 (95% CI: 0.65-0.96).
Conclusions:
- Current evidence for the effectiveness of injection therapies in managing low back pain is not convincing.
- There is a critical need for more rigorously designed, high-quality explanatory trials to clarify treatment benefits.